Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 55Endometrial Neoplasms 4Polycystic Ovary Syndrome 3Ovarian Neoplasms 3Neoplasm Metastasis 3Recurrence 2Neoplasms 2Infertility 2Carcinoma, Ductal, Breast 2Breast Neoplasm Female 2Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Neoplasms by Site 1Liposarcoma 1Inflammatory Breast Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Cystadenocarcinoma, Serous 1Colorectal Neoplasms 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Diseases 1Breast Cancer Female 1Anovulation 1Advanced Breast Carcinoma 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 2palbociclib 1Vorinostat 1Trastuzumab 1Taxes 1Tamoxifen 1Radiotherapy 1Paclitaxel 1Letrozole 1Fulvestrant 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Anastrozole 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Lobular × Letrozole × Clear all
NCT02764541 2025-05-07

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
195 enrolled 26 charts
Breast

Breast Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡